Ibaraki, Japan

Toshio Goto



Average Co-Inventor Count = 5.3

ph-index = 8

Forward Citations = 318(Granted Patents)


Location History:

  • Tsukuba, JP (1990)
  • Sakuramura, JP (1992 - 1993)
  • Kobe, JP (1995 - 1996)
  • Niihari, JP (1996)
  • Niihari-gun, JP (1997 - 2000)
  • Ibaraki, JP (1990 - 2002)

Company Filing History:


Years Active: 1990-2002

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Toshio Goto

Introduction

Toshio Goto is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. With a total of 17 patents to his name, Goto's work has had a substantial impact on medical science.

Latest Patents

Among his latest patents are methods for inhibiting interleukin-2 production using tricyclo compounds and methods for inhibiting lymphokine production. These inventions relate to tricyclo compounds that are useful for the treatment and prevention of resistance in transplantation, graft-versus-host diseases, autoimmune diseases, and infectious diseases.

Career Highlights

Toshio Goto is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in advancing pharmaceutical research and development. His innovative approaches have led to breakthroughs in the treatment of various medical conditions.

Collaborations

Throughout his career, Goto has collaborated with notable colleagues, including Masakuni Okuhara and Hirokazu Tanaka. These partnerships have fostered a collaborative environment that enhances the potential for innovation in their field.

Conclusion

Toshio Goto's contributions to pharmaceutical science through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of new treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…